机构地区:[1]河南省人民医院甲状腺外科,郑州450003 [2]河南省人民医院消毒供应中心,郑州450003
出 处:《中华实验外科杂志》2017年第11期1889-1891,共3页Chinese Journal of Experimental Surgery
摘 要:目的探讨黏蛋白1(MUC1)基因调控酪氨酸蛋白激酶(JAK)/信号转导与转录激活因子3(STAT3)信号通路抑制甲状腺癌细胞增殖及促进细胞凋亡的机制。方法Western blot检测甲状腺癌组织和癌旁组织中MUC1表达,将MUC1小干扰RNA(MUC1-siRNA)和阴性对照(siRNA-NC)转染人甲状腺癌细胞SW579,以空脂质体转染的细胞作为对照组,Western blot检测转染效果;细胞转染后培养48 h,细胞计数试剂盒(CCK-8)检测细胞增殖;流式细胞仪检测细胞凋亡;Western blot检测B细胞淋巴瘤/白血病-2相关X蛋白(bax)、B细胞淋巴瘤/白血病-2(bcl-2)、STAT3、磷酸化STAT3(p-STAT3)蛋白表达;细胞中加入15 μmol/L的JAK/STAT3信号通路的特异性抑制剂AG490,记为抑制剂组,不加抑制剂的设为未处理组,CCK-8及流式细胞仪检测两组细胞的增殖和凋亡,Western blot检测bax、bcl-2、STAT3、p-STAT3蛋白表达。结果MUC1在甲状腺癌组织(0.434±0.034)中的表达水平显著高于癌旁组织(0.153±0.018;t=12.651,P=0.000);MUC1-siRNA组细胞存活率[(55.38±7.12)%]、bcl-2(0.237±0.031)、p-STAT3(0.045±0.013)蛋白表达水平显著低于对照组[(94.32±5.21)%、0.425±0.034、0.122±0.025],细胞凋亡率[(16.29±1.23)%]及bax(0.248±0.026)蛋白表达水平显著高于对照组[(3.06±0.78)%、0.109±0.019],差异有统计学意义(t存活率=7.645,P存活率=0.002;tbcl-2=7.077,Pbcl-2=0.002;tp-STAT3=4.733,Pp-STAT3=0.009;t凋亡率=15.733,P凋亡率=0.000;tbax=7.476,Pbax=0.002)。细胞中加入抑制剂后的增殖与凋亡结果与转染MUC1-siRNA的结果一致。结论沉默MUC1的表达能显著抑制人甲状腺癌细胞SW579增殖,并通过调节bcl-2和bax的蛋白表达诱导细胞凋亡,其机制与JAK/STAT3信号通路有关。Objective To investigate the mechanism of membrane type mucin 1 ( MUC1 ) gene by regulated janus protein tyrosine kinase/signal transducer and activators of transcription 3 ( JAK/STAT3 ) signaling pathway to inhibit proliferation and promote apoptosis of thyroid cancer cells. Methods The ex- pression of MUC1 in thyroid carcinoma and adjacent tissues was detected by Western blotting, MUC1 small interfering RNA (MUC1 -siRNA) and negative control (siRNA- NC ) were transfeeted into human thy- roid cancer cells SW579, empty cells as the control group ; cells were transfected for 48 h, Western blotting was used to detect transfection effect ; cell proliferation was detected by cell counting kit - 8 ( CCK - 8 ) ; cell apoptosis was detected by flow cytometry ; the expression of B cell lymphoma/leukemia - 2 associated X protein ( bax), B cell lymphoma/leukemia - 2 ( bcl - 2), STAT3, phosphorylated STAT3 ( p - STAT3 ) protein was detected by Western blotting; 15 v, mol/L AG490 specific inhibitor of JAK/STAT3 signaling pathway to join cells as the inhibitor group, without inhibitors for the untreated group, cell proliferation and apoptosis in two group was detected by CCK - 8 and flow cytometry separately; the expression of bax, bcl - 2, STAT3, p - STAT3 protein was detected by Western blotting. Results The expression of MUC1 in thyroid carcinoma tissues ( 0.434 ± 0.034 ) was significantly higher than that in paracancerous tissues (0.153±0.018, t= 12.651, P=0.000); the cell survival rate [(55.38 ±7.12)%] and bel-2 (0. 237 s0. 031 ), p- STAT3 (0. 045 ± 0. 013 ) protein expression in MUC1 -siRNA group was signifi- cantly lower than the control group [ (94. 32±5. 21)%, 0. 425 ±0. 034, 0. 122±0. 025], cell apoptosis rate [ ( 16. 29±1.23) % ] and bax ( 0. 248±0. 026) protein expression was significantly higher than the eontrol group [ (3.06±0. 78)% , 0. 109 ±0. 019; tSurvival rate=7. 645, PSurvival rate=0. 002; tbcl-2=7. 077, Pbcl-2 = 0. 002 ; tpSTAT
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...